Canlyniadau Chwilio am Awdur :: Library Catalog

1

Figure 4 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Figure 1 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Figure 2 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Figure 3 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Cyhoeddwyd 2025
Awduron Eraill: “...Alison M. Meynert (14956260)...”

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma gan Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification gan Robert L. Hollis (15034814)

Offerynnau Chwilio: